Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available (further information necessary)

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No data on the repeated dose toxicity of the substance are available yet. The registrant will update the dossier after a sub-chronic (90 days) toxicity study has become available.


Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Taking into account that the tonnage band of 100 tonnes/year has been exceeded, the performance of a sub-chronic (90 days) toxicity study is required. Therefore, the registrant submits a testing proposal for a sub-chronic (90 days) toxicity study.

Justification for classification or non-classification

No data on the repeated dose toxicity of the substance are available yet. Classification or non-classification will be justified when respective data has become available.